Skip to main content
Clinical Trials/NCT01888094
NCT01888094
Completed
Phase 2

SUBclavian Central Venous Catheters Guidance and Examination by UltraSound : a Randomized Controlled Study Versus Landmark Method

University Hospital, Clermont-Ferrand1 site in 1 country300 target enrollmentJune 2013

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Requiring Subclavian Vein Cannulation
Sponsor
University Hospital, Clermont-Ferrand
Enrollment
300
Locations
1
Primary Endpoint
procedure time between the beginning of procedure ( TO) and when the catheter is controlled ( T4) between strategy catheter cannulation 'standard' and a strategy called "ultrasound all
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

Prospective, randomized controlled clinical unicentric study, in ICU, Cannulation of the subclavian venous and examination guided with ultrasound

Detailed Description

One groupe : Ultrasound guided for cannulation and examination of absence ofcomplications One groupe : landmark method and examination with chest radiography

Registry
clinicaltrials.gov
Start Date
June 2013
End Date
December 2015
Last Updated
9 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
University Hospital, Clermont-Ferrand
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • adults patients
  • requiring subclavian vein cannulation
  • patient covered by french health care system

Exclusion Criteria

  • patient refusal
  • requiring vein cannulation femoral or jugular
  • we see nothing with echocardiography
  • children and not adult patients

Outcomes

Primary Outcomes

procedure time between the beginning of procedure ( TO) and when the catheter is controlled ( T4) between strategy catheter cannulation 'standard' and a strategy called "ultrasound all

Time Frame: at day 1

Secondary Outcomes

  • incidence of occurrence of complications: pneumothorax, hemothorax, bad positioning (outside of the superior vena cava or the right atrium) between the two strategies(at day 1)
  • failure of technology between the two strategies.(at day 1)
  • occurrence of central venous catheter infection.(at day 1)
  • procedure time Tn-Tn (n 0-5) between the two strategies.(at day 1)

Study Sites (1)

Loading locations...

Similar Trials